e-learning
resources
Monograph
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The evaluation of disease severity/staging for prognosis
Oisin J. O'Connell, Jim J. Egan
Source:
Eur Respir Monogr 2016; 71: 97-105
Journal Issue:
Idiopathic Pulmonary Fibrosis
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Oisin J. O'Connell, Jim J. Egan. The evaluation of disease severity/staging for prognosis. Eur Respir Monogr 2016; 71: 97-105
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay.
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Acute exacerbations of IPF: A neglected threat in IPF ?
Related content which might interest you:
Markers of early disease and prognosis in COPD
Source: Annual Congress 2009 - Epidemiology of COPD
Year: 2009
Interstitial lung disease: improving classification and prognosis
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021
Time lost for diagnostics of lung carcinoma related to disease stage and prognosis
Source: Eur Respir J 2004; 24: Suppl. 48, 297s
Year: 2004
Determining the best diagnostic biomarker for sepsis and prognosis assessment
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012
Clinical features and outcomes of patients with myositis associated-interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
The experience of long-term prognosis evaluation of childhood asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 164s
Year: 2005
COPD detected with screening: impact on patient management and prognosis
Source: Eur Respir J 2014; 44: 1571-1578
Year: 2014
Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2014; 43: 1529-1530
Year: 2014
Prevalence and prognosis of unclassifiable interstitial lung disease
Source: Eur Respir J 2013; 42: 750-757
Year: 2013
Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Source: Eur Respir J 2016; 48: 281-282
Year: 2016
Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?
Source: Eur Respir J 2016; 48: 279-281
Year: 2016
The benefit of surgical lung biopsy in diagnosis and prognosis of diffuse infiltrative lung disease
Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery
Year: 2007
Clinical features and prognosis of Chinese sarcoidosis patients.
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
The effect of nutritional indicators on prognosis of patients with advanced lung cancer
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019
Pulmonary function evaluation in advanced Parkinson‘s disease
Source: Eur Respir J 2006; 28: Suppl. 50, 201s
Year: 2006
Sarcoidosis: imagiological findings and their impact on the disease outcome
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018
COPD: implementing biomarkers to improve prognosis
Source: Virtual Congress 2021 – Clinical year in review
Year: 2021
Lung cancer and hemostasis – the impact of subclinical thrombotic manifestations upon the prognosis: a prospective hospital study
Source: Eur Respir J 2006; 28: Suppl. 50, 386s
Year: 2006
When and how to communicate the prognosis in a chronic respiratory disease
Source: International Congress 2017 – End-of-life care of the respiratory patients
Year: 2017
CPET for prognosis assessment
Source: ERS Skills course - Clinical exercise testing: advanced
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept